At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

ARE YOU LOOKING TO MAKE A SIGNIFICANT CONTRIBUTION TO PUBLIC HEALTH AND PATIENT SAFETY THROUGH THE PRACTICE OF PHARMACOEPIDEMIOLOGY?

We are seeking an ambitious post-doctoral scientist with strong research and communication skills, to contribute to an impactful research project within the Global Patient Safety (GPS) Pharmacoepidemiology (PE) group. This role will help build internal scientific capabilities by developing a practical, evidence-based framework for conducting comparative analyses in observational studies. The objective is to establish clearer methodological standards and enhance the scientific validity and reliability of evidence generation from observational safety studies.

In this role, the post-doctoral scientist will have the opportunity to

• Develop a comprehensive understanding of common and emerging pharmacoepidemiologic methods and drive the adoption of a systematic methodological framework across the enterprise
• Accelerate the development of high-quality scientific protocols and strengthen the credibility of observational safety studies
• Increasing the acceptability of real-world evidence (RWE) for informing patient safety and regulatory decision-making.

In addition to work related to framework development, the post-doctoral scientist will have the opportunity to gain hands-on experience in the following areas:

• Leading and/or collaborating on the design, execution, and interpretation of pharmacoepidemiology studies
• Supporting the development and execution of risk management plans and specialized risk minimization activities.
• Identifying and evaluating potential safety signals and supporting communication with global regulatory authorities.
• Collaborating with cross-functional teams (e.g., regulatory, clinical development) to address research and regulatory questions
• Contributing to scientific publications, regulatory submissions, and conference presentations.
• Characterizing the natural history of diseases.

Employment for this position will be in-person at Lilly Corporate Center in Indianapolis, Indiana. The post-doctoral scientist will work closely with other members of the PE team, the broader GPS organization, and with cross-functional teams including Statistics, Clinical Development, Regulatory Affairs, and others.

BASIC QUALIFICATIONS:

• A PhD or DrPH in epidemiology or other subject with high epidemiologic content

• Develop a comprehensive understanding of common and emerging pharmacoepidemiologic methods and drive the adoption of a systematic methodological framework across the enterprise
• Accelerate the development of high-quality scientific protocols and strengthen the credibility of observational safety studies
• Increasing the acceptability of real-world evidence (RWE) for informing patient safety and regulatory decision-making